Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Novavax, Inc. (NVAX) had Return on Investments of -226.29% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$70.44M |
|
$-202.38M |
|
$21.50M |
|
$48.95M |
|
$248.46M |
|
$-178.02M |
|
$-25.02M |
|
$-203.04M |
|
$-203.04M |
|
$-202.38M |
|
$-202.38M |
|
$-202.38M |
|
$-202.38M |
|
$-178.02M |
|
$-171.43M |
|
162.35M |
|
162.35M |
|
$-1.25 |
|
$-1.25 |
|
| Balance Sheet Financials | |
$974.59M |
|
$49.12M |
|
$205.30M |
|
$1.18B |
|
$429.87M |
|
$246.10M |
|
$906.69M |
|
$1.34B |
|
$-156.67M |
|
$-269.75M |
|
$-156.67M |
|
162.47M |
|
| Cash Flow Statement Financials | |
$-205.16M |
|
$-98.75M |
|
$34.34M |
|
$545.29M |
|
$283.36M |
|
$-261.94M |
|
$28.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
2.75 |
|
-1.60 |
|
69.49% |
|
-252.71% |
|
-252.71% |
|
-- |
|
-288.22% |
|
-287.29% |
|
$-208.64M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
1.59 |
|
2.06 |
|
43.66 |
|
129.17% |
|
75.02% |
|
-17.15% |
|
|
Return on Investments |
-226.29% |
$-0.96 |
|
$-1.29 |
|
$-1.26 |
|